THOMAS SIUDZINSKI: Open Payments
NPI 1912436965 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$975 in 54 payments from 16 companies in 2025. Trend: 2023 $659 · 2024 $660 · 2025 $975
Food & beverage: $975
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 12 | $160 |
| Alnylam Pharmaceuticals Inc. | 7 | $129 |
| E.R. Squibb & Sons, L.L.C. | 7 | $110 |
| Edwards Lifesciences Corporation | 3 | $92 |
| Novartis Pharmaceuticals Corporation | 5 | $82 |
| PFIZER INC. | 4 | $80 |
| Merck Sharp & Dohme LLC | 3 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $64 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Impulse Dynamics (USA) Inc. | 1 | $30 |
Products named: ONPATTRO, LUX-Dx Insertable Cardiac Monitor, LEQVIO, CAMZYOS, ELIQUIS, JARDIANCE, VERQUVO, VYNDAQEL.
Industry payments across NY — which companies pay providers there.
